Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma

Journal of Pathology

Volumn 214, Issue 4, 2008, Pages 489-497

  Liu, C J ^a,b,c   Liu, T Y ^d   Kuo, L T ^c   Cheng, H W ^a   Chu, T H ^c   Chang, K W ^c,d   Lin, S C ^c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

cDNA microarray; Head and neck; IGFBP6; Metastasis; SELL

Indexed keywords

ALPHA LEVO FUCOSIDASE; EARLY GROWTH RESPONSE FACTOR 2; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; NEUROPSIN; REGULATOR OF G PROTEIN SIGNALING 1 PROTEIN; REGULATOR PROTEIN; SOMATOMEDIN BINDING PROTEIN 6; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ALGORITHM; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MICROARRAY ANALYSIS; MICRODISSECTION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT; UPREGULATION;

EID: 40349103687     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2306     Document Type: Article

References (33)

1. 1 Chen YJ, Lin SC, Kao T, Chang CS, Hong PS, Shieh TM, et al. Genome‐wide profiling of oral squamous cell carcinoma. J Pathol 2004 ; 204: 326–332.
2. 2 Lin SC, Wang CP, Chen YM, Lu SY, Fann MJ, Liu CJ, et al. Regulation of IGFBP‐5 expression during tumourigenesis and differentiation of oral keratinocytes. J Pathol 2002 ; 198: 317–325.
3. 3 Shieh TM, Lin SC, Liu CJ, et al. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca‐associated oral tumorigenesis. Clin Cancer Res 2007 ; 13: 4378–4385.
4. 4 Marcus B, Arenberg D, Lee J, Kleer C, Chepeha DB, Schmalbach CE, et al. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 2004 ; 101: 2779–2787.
5. 5 Lo WL, Kao SY, Chi LY, Wong YK, Chang RC. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg 2003 ; 61: 751–758.
6. 6 Sessions DG, Lenox J, Spector GJ, Chao C, Chaudry OA. Analysis of treatment results for base of tongue cancer. Laryngoscope 2003 ; 113: 1252–1261.
7. 7 Wreesmann VB, Wang D, Goberdhan A, Prasad M, Nagi I, Schnaser EA, et al. Genetic abnormalities associated with nodal metastasis in head and neck cancer. Head Neck 2004 ; 26: 10–15.
8. 8 Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nature Rev Cancer 2003 ; 3: 55–63.
9. 9 Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 2003 ; 4: 51–62.
10. 10 Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 2001 ; 20: 6196–6204.
11. 11 Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004 ; 5: 489–500.
12. 12 Nagata M, Fujita H, Ida H, Hoshina H, Inoue T, Seki Y, et al. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 2003 ; 106: 683–689.
13. 13 Nguyen ST, Hasegawa S, Tsuda H, Tomioka H, Ushijima M, Noda M, et al. Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma. Cancer Sci 2007 ; 98: 740–746.
14. 14 O'Donnell RK, Kupferman M, Wei SJ, Singhal S, Weber R, O'Malley B, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005 ; 24: 1244–1251.
15. 15 Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nature Genet 2005 ; 37: 182–186.
16. 16 Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004 ; 130: 295–302.
17. 17 Warner GC, Reis PP, Jurisica I, Sultan M, Arora S, Macmillan C, et al. Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer 2004 ; 110: 857–868.
18. 18 Roepman P, de Jager A, Groot Koerkamp MJ, Kummer JA, Slootweg PJ, Holstege FC. Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis. Cancer Res 2006 ; 66: 11110–11114.
19. 19 Liu CJ, Lin SC, Chen YJ, Chang KM, Chang KW. Array‐comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol Carcinog 2006 ; 45: 721–731.
20. 20 Lu SY, Chang KW, Liu CJ, Tseng YH, Lu HH, Lee SY, et al. Ripe areca nut extract induces G1 phase arrests and senescence‐associated phenotypes in normal human oral keratinocyte. Carcinogenesis 2006 ; 27: 1273–1284.
21. 21 Roepman P, de Koning E, van Leenen D, de Weger RA, Kummer AJ, Slootweg PJ, et al. Dissection of a metastatic gene expression signature into distinct components. Genome Biol 2006 ; 7: R117.
22. 22 Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res, 2004 ; 64: 55–63.
23. 23 Witz IP. Tumor–microenvironment interactions: the selectin–selectin ligand axis in tumor–endothelium cross talk. Cancer Treat Res 2006 ; 130: 125–140.
24. 24 Laubli H, Stevenson JL, Varki A, Varki NM, Borsig L. L‐selectin facilitation of metastasis involves temporal induction of Fut7‐dependent ligands at sites of tumor cell arrest. Cancer Res 2006 ; 66: 1536–1542.
25. 25 Jutila MA, Kurk S, Jackiw L, Knibbs RN, Stoolman LM. L‐selectin serves as an E‐selectin ligand on cultured human T lymphoblasts. J Immunol 2002 ; 169: 1768–1773.
26. 26 Borsig L, Wong R, Hynes RO, Varki NM, Varki A. Synergistic effects of L‐ and P‐selectin in facilitating tumor metastasis can involve non‐mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci U S A 2002 ; 99: 2193–2198.
27. 27 Smalley DM, Ley K. L‐selectin: mechanisms and physiological significance of ectodomain cleavage. J Cell Mol Med 2005 ; 9: 255–266.
28. 28 Jeon GA, Lee JS, Patel V, Gutkind JS, Thorgeirsson SS, Kim EC, et al. Global gene expression profiles of human head and neck squamous carcinoma cell lines. Int J Cancer 2004 ; 112: 249–258.
29. 29 Shitara E, Nishimura Y, Kojima F, Takeuchi T. Gem‐diamine 1‐N‐iminosugars of L‐fucose‐type, the extremely potent L‐fucosidase inhibitors. Bioorg Med Chem 2000 ; 8: 343–352.
30. 30 Han JI, Huang NN, Kim DU, Kehrl JH. RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. J Leukoc Biol 2006 ; 79: 1357–1368.
31. 31 Wang J, Zhang X, Thomas SM, Grandis JR, Wells A, Chen ZG, et al. Chemokine receptor 7 activates phosphoinositide‐3 kinase‐mediated invasive and pro‐survival pathways in head and neck cancer cells independent of EGFR. Oncogene 2005 ; 24: 5897–5904.
32. 32 Barel M, Balbo M, Le Romancer M, Frade R. Activation of Epstein–Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt‐GSK3 activities upstream and downstream to PI 3‐kinase, respectively. Eur J Immunol 2003 ; 33: 2557–2566.
33. 33 Sher YP, Chou CC, Chou RH, Wu HM, Wayne Chang WS, Chen CH, et al. Human kallikrein 8 protease confers a favorable clinical outcome in non‐small cell lung cancer by suppressing tumor cell invasiveness. Cancer Res 2006 ; 66: 11763–11770.